UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

The heterogeneity of systemic inflammation in bronchiectasis

Saleh, AD; Chalmers, JD; De Soyza, A; Fardon, TC; Koustas, SO; Scott, J; Simpson, AJ; ... Hurst, JR; + view all (2017) The heterogeneity of systemic inflammation in bronchiectasis. Respiratory Medicine , 127 pp. 33-39. 10.1016/j.rmed.2017.04.009. Green open access

[thumbnail of Hurst_Bx Cytokines_Final Revision_Clean.pdf]
Preview
Text
Hurst_Bx Cytokines_Final Revision_Clean.pdf - Accepted Version

Download (601kB) | Preview

Abstract

BACKGROUND: Systemic inflammation in bronchiectasis is poorly studied in relation to aetiology and severity. We hypothesized that molecular patterns of inflammation may define particular aetiology and severity groups in bronchiectasis. METHOD: We assayed blood concentrations of 31 proteins from 90 bronchiectasis patients (derivation cohort) and conducted PCA to examine relationships between these markers, disease aetiology and severity. Key results were validated in two separate cohorts of 97 and 79 patients from other centres. RESULTS: There was significant heterogeneity in protein concentrations across the derivation population. Increasing severity of bronchiectasis (BSI) was associated with increasing fibrinogen (rho = 0.34, p = 0.001 -validated in a second cohort), and higher fibrinogen was associated with worse lung function, Pseudomonas colonisation and impaired health-status. There were generally similar patterns of inflammation in patients with idiopathic and post-infectious disease. However, patients with primary immunodeficiency had exaggerated IL-17 responses, validated in a second cohort (n = 79, immunodeficient 12.82 pg/ml versus idiopathic/post-infectious 4.95 pg/ml, p = 0.001), and thus IL-17 discriminated primary immunodeficiency from other aetiologies (AUC 0.769 (95%CI 0.661-0.877)). CONCLUSION: Bronchiectasis is associated with heterogeneity of systemic inflammatory proteins not adequately explained by differences in disease aetiology or severity. More severe disease is associated with enhanced acute-phase responses. Plasma fibrinogen was associated with bronchiectasis severity in two cohorts, Pseudomonas colonisation and health status, and offers potential as a useful biomarker.

Type: Article
Title: The heterogeneity of systemic inflammation in bronchiectasis
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.rmed.2017.04.009
Publisher version: http://dx.doi.org/10.1016/j.rmed.2017.04.009
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Acute-phase reaction, Bronchiectasis, Fibrinogen, Inflammation, Interleukin-17
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Respiratory Medicine
URI: https://discovery.ucl.ac.uk/id/eprint/1556976
Downloads since deposit
97Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item